Cargando…

Proteome coverage prediction with infinite Markov models

Motivation: Liquid chromatography tandem mass spectrometry (LC-MS/MS) is the predominant method to comprehensively characterize complex protein mixtures such as samples from prefractionated or complete proteomes. In order to maximize proteome coverage for the studied sample, i.e. identify as many tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassen, Manfred, Aebersold, Ruedi, Buhmann, Joachim M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687987/
https://www.ncbi.nlm.nih.gov/pubmed/19477982
http://dx.doi.org/10.1093/bioinformatics/btp233
_version_ 1782167636448116736
author Claassen, Manfred
Aebersold, Ruedi
Buhmann, Joachim M.
author_facet Claassen, Manfred
Aebersold, Ruedi
Buhmann, Joachim M.
author_sort Claassen, Manfred
collection PubMed
description Motivation: Liquid chromatography tandem mass spectrometry (LC-MS/MS) is the predominant method to comprehensively characterize complex protein mixtures such as samples from prefractionated or complete proteomes. In order to maximize proteome coverage for the studied sample, i.e. identify as many traceable proteins as possible, LC-MS/MS experiments are typically repeated extensively and the results combined. Proteome coverage prediction is the task of estimating the number of peptide discoveries of future LC-MS/MS experiments. Proteome coverage prediction is important to enhance the design of efficient proteomics studies. To date, there does not exist any method to reliably estimate the increase of proteome coverage at an early stage. Results: We propose an extended infinite Markov model DiriSim to extrapolate the progression of proteome coverage based on a small number of already performed LC-MS/MS experiments. The method explicitly accounts for the uncertainty of peptide identifications. We tested DiriSim on a set of 37 LC-MS/MS experiments of a complete proteome sample and demonstrated that DiriSim correctly predicts the coverage progression already from a small subset of experiments. The predicted progression enabled us to specify maximal coverage for the test sample. We demonstrated that quality requirements on the final proteome map impose an upper bound on the number of useful experiment repetitions and limit the achievable proteome coverage. Contact: manfredc@inf.ethz.ch; jbuhmann@inf.ethz.ch
format Text
id pubmed-2687987
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-26879872009-06-02 Proteome coverage prediction with infinite Markov models Claassen, Manfred Aebersold, Ruedi Buhmann, Joachim M. Bioinformatics Ismb/Eccb 2009 Conference Proceedings June 27 to July 2, 2009, Stockholm, Sweden Motivation: Liquid chromatography tandem mass spectrometry (LC-MS/MS) is the predominant method to comprehensively characterize complex protein mixtures such as samples from prefractionated or complete proteomes. In order to maximize proteome coverage for the studied sample, i.e. identify as many traceable proteins as possible, LC-MS/MS experiments are typically repeated extensively and the results combined. Proteome coverage prediction is the task of estimating the number of peptide discoveries of future LC-MS/MS experiments. Proteome coverage prediction is important to enhance the design of efficient proteomics studies. To date, there does not exist any method to reliably estimate the increase of proteome coverage at an early stage. Results: We propose an extended infinite Markov model DiriSim to extrapolate the progression of proteome coverage based on a small number of already performed LC-MS/MS experiments. The method explicitly accounts for the uncertainty of peptide identifications. We tested DiriSim on a set of 37 LC-MS/MS experiments of a complete proteome sample and demonstrated that DiriSim correctly predicts the coverage progression already from a small subset of experiments. The predicted progression enabled us to specify maximal coverage for the test sample. We demonstrated that quality requirements on the final proteome map impose an upper bound on the number of useful experiment repetitions and limit the achievable proteome coverage. Contact: manfredc@inf.ethz.ch; jbuhmann@inf.ethz.ch Oxford University Press 2009-06-15 2009-05-27 /pmc/articles/PMC2687987/ /pubmed/19477982 http://dx.doi.org/10.1093/bioinformatics/btp233 Text en © 2009 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Ismb/Eccb 2009 Conference Proceedings June 27 to July 2, 2009, Stockholm, Sweden
Claassen, Manfred
Aebersold, Ruedi
Buhmann, Joachim M.
Proteome coverage prediction with infinite Markov models
title Proteome coverage prediction with infinite Markov models
title_full Proteome coverage prediction with infinite Markov models
title_fullStr Proteome coverage prediction with infinite Markov models
title_full_unstemmed Proteome coverage prediction with infinite Markov models
title_short Proteome coverage prediction with infinite Markov models
title_sort proteome coverage prediction with infinite markov models
topic Ismb/Eccb 2009 Conference Proceedings June 27 to July 2, 2009, Stockholm, Sweden
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687987/
https://www.ncbi.nlm.nih.gov/pubmed/19477982
http://dx.doi.org/10.1093/bioinformatics/btp233
work_keys_str_mv AT claassenmanfred proteomecoveragepredictionwithinfinitemarkovmodels
AT aebersoldruedi proteomecoveragepredictionwithinfinitemarkovmodels
AT buhmannjoachimm proteomecoveragepredictionwithinfinitemarkovmodels